Oral Abstract Session:
137. Sexually Transmitted Infections
Friday, October 4, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 250-262

Learning Objectives:

-

Target Audience: HIV clinicians, HIV specialists, infectious diseases physicians

Topical Category: C. Clinical Infectious Diseases

Tracks: HIV-STD-TB

Moderator:  Gail Bolan, MD, California Department of Public Health

Presentations:

2:00 PM
Statewide Survey of Emergency Department Practice for Prophylaxis of Sexually Trasmitted Infections in Rape Victims
Adrienne Crow, MD ; Taalibah Ahmed, MD ; Ritu Kumar, MD ; Harold Katner, MD

2:30 PM
A Single Dose of Benzathine Pencillin is Sufficient for the Treatment of HIV-infected Persons with Early Syphilis
Anuradha Ganesan, MBBS, MPH ; Octavio Mesner, MS ; William P. Bradley, MS ; Jason Okulicz, MD ; Amy Weintrob, MD ; Tahaniyat Lalani, MBBS, MHS ; Mary Bavaro, MD ; Timothy Whitman, DO ; Chris Olsen ; Grace E Macalino, PhD ; Brian Agan, MD

2:45 PM
Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men who have sex with men (MSM) compared with men who have sex with women (MSW) in the SUN Study
Pragna Patel, MD ; Tim Bush, MD ; Erna Kojic, MD ; Lois Conley, MPH ; Elizabeth Unger, MD PhD ; Theresa Darragh, MD ; Keith Henry, MD ; John Hammer, MD ; Nur Onen, BSc, MBChB ; Joel Palefsky, MD ; John T. Brooks, MD

3:00 PM
The Etiology of Vaginal Symptoms in Rural Haiti
Claire Bristow, MSc ; David Cutler, MD ; Tania Desgrottes, MD ; Karthika Devarajan, MD ; Lauren Cutler, BA ; Oksana Ocheretina, PhD ; Jean William Pape, MD ; Daniel Fitzgerald, MD ; Jeffrey Klausner, MD, MPH

3:15 PM
Mycoplasma genitalium:Prevalence and Clinical Significance in a Gynecologic Cohort
Oluwatosin Jaiyeoba, MD ; Cassandra Salgado, MD, MS ; David Soper, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

G. Bolan, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.